Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Epidermal growth factor as a reliable marker of necrotizing enterocolitis in preterm neonates

  • Lee, Na Mi (Department of Pediatrics, Chung-Ang University Hospital, College of Medicine, Chung-Ang University)
  • Received : 2019.05.03
  • Accepted : 2019.09.18
  • Published : 2020.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Yang J, Su Y, Zhou Y, Besner GE. Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: application and future prospects. Pathophysiology 2014;21:95-104. https://doi.org/10.1016/j.pathophys.2013.11.008
  2. Coursodon CF, Dvorak B. Epidermal growth factor and necrotizing enterocolitis. Curr Opin Pediatr 2012;24:160-4. https://doi.org/10.1097/MOP.0b013e3283504ddb
  3. Isani MA, Delaplain PT, Grishin A, Ford HR. Evolving understanding of neonatal necrotizing enterocolitis. Curr Opin Pediatr 2018;30:417-23. https://doi.org/10.1097/MOP.0000000000000629
  4. Wei J, Zhou Y, Besner GE. Heparin-binding EGF-like growth factor and enteric neural stem cell transplantation in the prevention of experimental necrotizing enterocolitis in mice. Pediatr Res 2015;78:29-37. https://doi.org/10.1038/pr.2015.63
  5. Halpern MD, Denning PW. The role of intestinal epithelial barrier function in the development of NEC. Tissue Barriers 2015;3:e1000707. https://doi.org/10.1080/21688370.2014.1000707
  6. Warner BW, Warner BB. Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis. Semin Pediatr Surg 2005;14:175-80. https://doi.org/10.1053/j.sempedsurg.2005.05.006
  7. Khailova L, Dvorak K, Arganbright KM, Williams CS, Halpern MD, Dvorak B. Changes in hepatic cell junctions structure during experimental necrotizing enterocolitis: effect of EGF treatment. Pediatr Res 2009;66:140-4. https://doi.org/10.1203/PDR.0b013e3181aa3198
  8. Ahmed HM, Kamel NM. The relation between serum levels of epidermal growth factor and necrotizing enterocolitis in preterm neonates. Korean J Pediatr 2019;62:307-11. https://doi.org/10.3345/kjp.2018.07108
  9. He Y, Schmidt MA, Erwin C, Guo J, Sun R, Pendarvis K, et al. Transgenic soybean production of bioactive human epidermal growth factor (EGF). PLoS One 2016;11:e0157034. https://doi.org/10.1371/journal.pone.0157034
  10. Isani M, Illingworth L, Herman E, Schmidt M, Barron L, Bowling J, et al. Soybean-derived recombinant human epidermal growth factor protects against experimental necrotizing enterocolitis. J Pediatr Surg 2018;53:1203-7. https://doi.org/10.1016/j.jpedsurg.2018.02.084